Nuwellis (NUWE) Debt Ratio (2015 - 2016)
Nuwellis' (NUWE) quarterly Debt Ratio came in at 0.45 in Q2 2016, up 736.77% on a YoY basis from 0.05 in Q3 2015, and up 18.72% quarter-over-quarter from 0.38 in Q1 2016.
Analysis
Nuwellis (NUWE) Debt Ratio (2015 - 2016) Analysis & Trends
Nuwellis (NUWE) has reported Debt Ratio for 2 consecutive years, with 0.45 the latest figure, recorded in Q2 2016.
- For the quarter ending Q2 2016, Debt Ratio rose 736.77% year-over-year to 0.45; the trailing twelve-month figure through Jun 2016 stood at 0.45 (up 736.77% YoY), and the FY2015 full-year result was 0.31, changed N/A from the prior year.
- Debt Ratio grew to 0.45 in Q2 2016 per NUWE's latest filing, from 0.38 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.45 in Q2 2016 and bottomed at 0.02 in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 0.30 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 0.30 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 0.31 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.28 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.04 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.13 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 0.20 |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 0.45 |
| Mar 31, 2016 | 0.38 |
| Dec 31, 2015 | 0.31 |
| Sep 30, 2015 | 0.10 |
| Jun 30, 2015 | 0.05 |
| Mar 31, 2015 | 0.02 |